What cell types are considered high-grade salivary gland cancers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

High-Grade Salivary Gland Cancer Cell Types

High-grade salivary gland cancers include salivary duct carcinoma, high-grade mucoepidermoid carcinoma, solid-type adenoid cystic carcinoma, carcinoma ex pleomorphic adenoma, and high-grade transformation of low/intermediate-grade carcinomas. 1

Primary High-Grade Salivary Carcinoma Types

Definitively High-Grade Types

  1. Salivary Duct Carcinoma (SDC)

    • Considered one of the most aggressive salivary malignancies
    • Characterized by histologic resemblance to breast carcinoma
    • High-grade cytologic features and expression of androgen receptor 2
    • Has >20% rate of clinically positive nodal involvement at presentation 3
  2. High-Grade Mucoepidermoid Carcinoma

    • Graded in a three-tier system based on:
      • Cystic component
      • Border characteristics
      • Mitotic activity
      • Cellular anaplasia
      • Perineural invasion 4
    • High-grade variants have poor prognosis
  3. Solid-Type Adenoid Cystic Carcinoma

    • Graded based on pattern, with solid components indicating worse prognosis 4
    • When solid components exceed 30% of the tumor, it's considered high-grade 1
  4. Carcinoma ex Pleomorphic Adenoma (High-Grade)

    • Not automatically high-grade as traditionally thought
    • Must be qualified by type/grade of carcinoma and extent of invasion
    • High-grade variants have aggressive behavior 2
    • When the malignant component is high-grade, prognosis is poor 3
  5. Adenocarcinoma Not Otherwise Specified (NOS)

    • Now termed "salivary carcinoma, NOS"
    • High-grade variants have >20% rate of clinically positive nodal involvement 3

High-Grade Transformation

Several salivary gland tumors can undergo high-grade transformation:

  • Low or intermediate-grade tumors that transform to high-grade carcinomas
  • Adenoid cystic carcinomas may transform to pleomorphic high-grade carcinomas
  • This transformation confers high propensity for lymph node metastasis 4
  • Secretory carcinomas with high-grade transformation may be candidates for anti-TRK therapy 1

Clinical Implications of High-Grade Status

The identification of high-grade salivary carcinomas has significant treatment implications:

  1. Surgical Management

    • For high-grade parotid cancers, at least a superficial parotidectomy with consideration of total/subtotal parotidectomy is recommended 3
    • Facial nerve resection is indicated when branches are encased or grossly involved 3
  2. Neck Management

    • Elective neck treatment (dissection or radiation) is strongly recommended for all high-grade malignancies, even with clinically negative neck 3
    • High-grade histologies have the highest rates of occult nodal disease 3
  3. Adjuvant Therapy

    • Routine postoperative radiotherapy is indicated for all high-grade tumors (stages II-IV) 3
    • The combination of surgery and radiotherapy is the treatment of choice for high-grade disease 3

Diagnostic Challenges

Accurate grading is essential but challenging due to:

  • Histologic overlap between different tumor types
  • Morphologic heterogeneity within tumors
  • Rarity of these tumors 1

Detailed histological evaluation with adequate sampling and appropriate molecular ancillary tests is crucial for proper diagnosis and treatment planning 1.

Treatment Considerations

Treatment decisions should be based on both histologic grade and clinical stage:

  • Even for stage I high-grade tumors with complete resection, close follow-up is essential
  • For stage II-IV high-grade tumors, multimodality treatment with surgery and radiation is standard 3
  • Targeted therapies may be available for specific high-grade subtypes (e.g., androgen deprivation and anti-HER2 therapies for salivary duct carcinoma) 1

Regular follow-up is critical as approximately 70% of recurrences of high-grade malignant salivary gland tumors occur within the first 3 years after treatment 3.

References

Research

Update on selected salivary gland neoplasms.

Archives of pathology & laboratory medicine, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An update on grading of salivary gland carcinomas.

Head and neck pathology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.